Rejected at 9:32 p.m. Oct, 16, 2024 ] by rpmoore
Author: jaguar2021
Related Note: 1462913839886 4
Rationale for change

This is incorrect. SGLT-2 inhibitors are not contraindicated in patients with renal insufficiency, and can actually help reduce the reduction in eGFR. See https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263228/ for a review on how SGLT-2 inhibitors can decrease the decline in eGFR for both stage 4 CKD and CKD without albinuria.

Rejection reason

Please resubmit with an acceptable rationale. Please review suggestion guidelines, specifically rule #2: 📚 AnKing Step Deck Submission Guidelines

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::09_SGLT2_Inhibitors #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::01_Diabetes_mellitus_therapy::*SGLT2_Inhibitors #AK_Step1_v12::#UWorld::COMLEX::23717 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #AK_Step1_v12::#UWorld::Step::604 #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::07_Sodium-glucose_Cotransporter_2_(SGLT2)_Inhibitors #AK_Step1_v12::#AMBOSS::mdaVqj #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::06_Retired_Lessons::03_Metformin,_thiazolidinediones,_pramlintide,_SGLT2_inhibitors_[Retired_Video] #AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step1_v12::#Bootcamp::Endocrinology::07_Pancreas::09_Diabetes_Type_2_Management #PANCE::EOR::IM #PANCE::ENDO::diabetes #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::02_Metformin,_Thiazolidinediones,_Pramlintide,_SGLT2_Inhibitors #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::02_Diabetes_Management #AK_Step1_v12::#AMBOSS::0WaePj